Finance

Lists
Why is ONCSM down 2.98%?
Dive Deeper
ONCSM:IST
Oncosem Onkolojik Sistemlr Sny v Tcrt AS
TRY 101.10
-2.98%
(-3.10) 1D
Nov 13, 6:10:00 PM GMT+3  ·   TRY
All symbols
SymbolPriceChange% Change
Generating top insights for ONCSM...
Open
TRY 104.20
High
TRY 106.70
Low
TRY 101.10
Mkt. cap
2.41B
Avg. vol.
1.30M
Volume
1.23M
P/E ratio
33.39
52-wk high
TRY 389.75
52-wk low
TRY 77.00
EPS
TRY 3.03
Shares outstanding
23.85M
No. of employees
411
Open
TRY 104.20
High
TRY 106.70
Low
TRY 101.10
Mkt. cap
2.41B
Avg. vol.
1.30M
Volume
1.23M
P/E ratio
33.39
52-wk high
TRY 389.75
52-wk low
TRY 77.00
EPS
TRY 3.03
Shares outstanding
23.85M
No. of employees
411
News stories
From web sources and news partners
About Oncosem Onkolojik Sistemlr Sny v Tcrt AS
CEO-
Employees411
Founded2008
Headquarters-
SectorHealth Care
IndustryMedical device
Previous reportsAll values in TRY
Loading Previous Earnings...
Revenue
Net income
All values in TRY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
185.71M
255.77M
221.71M
305.84M
Cost of goods sold
60.42M
116.30M
101.92M
162.62M
Cost of revenue
60.42M
116.30M
101.92M
162.62M
Research and development expenses
432.27K
539.14K
4.58M
4.47M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
30.88M
76.29M
49.87M
67.06M
Operating expense
33.16M
82.38M
54.67M
77.87M
Total operating expenses
93.58M
198.68M
156.59M
240.49M
Operating income
92.14M
57.08M
65.12M
65.35M
Other non operating income
-24.71M
-25.84M
-13.03M
-14.89M
EBT including unusual items
59.46M
13.42M
36.44M
37.44M
EBT excluding unusual items
58.58M
13.00M
36.44M
37.44M
Income tax expense
34.58M
7.05M
11.80M
9.64M
Effective tax rate
58.16%
52.58%
32.40%
25.75%
Other operating expenses
1.85M
5.55M
216.48K
6.35M
Net income
24.88M
6.36M
24.63M
27.80M
Net profit margin
13.39%
2.49%
11.11%
9.09%
Earnings per share
-
-
-
-
Interest and investment income
1.35M
973.19K
129.21K
127.43K
Interest expense
-9.46M
-18.66M
-15.75M
-13.14M
Net interest expenses
-8.11M
-17.68M
-15.63M
-13.01M
Depreciation and amortization charges
-
-
-
-
EBITDA
108.25M
71.85M
81.26M
92.36M
Gain or loss from assets sale
843.19K
41.67K
-
-213.08K
Upcoming events
AI content may include mistakes. Learn more
Google apps